| David James Wehrly, MD | |
|
107 Nathan Ln, Oak Ridge, TN 37830-8128 | |
| (865) 482-3666 | |
| Not Available |
| Full Name | David James Wehrly |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 107 Nathan Ln, Oak Ridge, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184843716 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| David James Wehrly, MD 107 Nathan Ln, Oak Ridge, TN 37830-8128 Ph: (865) 482-3666 | David James Wehrly, MD 107 Nathan Ln, Oak Ridge, TN 37830-8128 Ph: (865) 482-3666 |
News Archive
The New York Times profiles two AIDS patients whose cases "suggest to many scientists that curing AIDS may be achievable," according to the newspaper. "One man, the so-called Berlin patient, apparently has cleared his HIV infection, albeit by arduous bone marrow transplants," and the other, "a 50-year-old man in Trenton, N.J., underwent a far less difficult gene therapy procedure. While he was not cured, his body was able to briefly control the virus after he stopped taking the usual antiviral drugs, something that is highly unusual," the newspaper writes.
A new patent has been issued to Moffitt Cancer Center for a computerized system that efficiently selects the right patient for the right clinical trial. The newly patented system matches the registered patient's own molecular profile - warehoused in a database of thousands of patient-donated biological tissue or tumor samples - to the molecular design of the drug aimed at targeting their disease at the molecular level, and does it quickly.
Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced plans to submit a Phase III trial design for DAVANAT to the U.S. Food and Drug Administration during the second half of 2010. The Company has added the talent of Peter G. Traber, M.D., to its FDA approval strategy and trial design team.
Zipnosis is getting the word out about an incredibly effective means of avoiding the spread of germs this cold and flu season: Use virtual care.
› Verified 4 days ago
Timothy R Oesch, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1030 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 615-778-4066 | |
Carol J Iddins, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1299 Bethel Valley Rd, Box 117 Reacts, Oak Ridge, TN 37830 Phone: 865-576-3131 Fax: 865-576-9522 |